NURS5463 Exam 2
Leave the first rating
Save
Students also studied
Heme clinicals exam 2 Hematology ASCP BOC Advanced Pathophysiology Exam 2... MMSC
134 terms Teacher 377 terms Teacher 129 terms 103 term
watuwachafu Preview hillamwangi12 Preview Euro_Futbal Preview wat
Practice questions for this set
Learn 1 /7 Study with Learn
brain, spine, and blood cancers
Choose an answer
1 TNM cancer staging only in> 2 TNM cancer staging including>
3 TNM cancer staging excluding> 4 TNM cancer staging except in>
Don't know?
Terms in this set (129)
high probability for DVT? Wells Score >2
high probability for PE? Wells criteria >6
high risk for bleeding 0-3 months? >2 risk factors = no anticoagulation
contraindicated in renal patients and Factor Xa inhibitors
mechanical heart valve patients?
1st line anticoagulation in cancer patients? LMWH
all VTE treated in what patients? cancer patients
, CI in GFR <30 LMWH and Fondaparinux, prescribe heparin
high risk for VTE via padua prediction? >4, need pharmacologics unless high risk of bleeding >2
low risk padua prediction <4 in nonsurgical no prophylaxis needed
patients?
prophylaxis in orthopedic patients? LMWH for 10-14 days
most common inherited thrombophilia? Factor V Leiden
PCR testing- G20210A? Prothrombin Mutation
mutation on chromosome 3 PROS1 mutation in PRrotein S deficiency
anticoagulants except heparin and LMWH free protein S levels, protein C function assay, and antithrombin functional assay
& VTE within 3 months interferes with what
testing?
hemophilia A factor deficiency? factor VIII, sex linked recessive
factor replacement and dDAVP treatment? hemophilia A
factor ? in hemophilia B? factor IX
? prolonged in hemophilias? PTT
ADAMTS13 deficient <10% confirms Dx? Thrombotic thrombocytopenia purpura TTP
plasma vWF <30 and factor VIII normal? Von Willebrand Disease
treatment of type 1 and some of type 2 dDAVP
vWD?
treatment of some type 2 and all type 3 recombinant vWF
vWD?
LDH high, bilirubin high? TTP and ITP
dexamethasone slows destruction of plts TTP and ITP
in?
transfuse plt in TTP or ITP when? severe bleeding or plt <30,000
plt destruction and the severe form? HIT 2
DX of HIT 2? ELISA OD >1.5 and high 4T score probability and serotonin release assay
1st choice DOAC in nonbleeding HIT 2 Argatroban IV to reduce HIT thrombosis
patients?
prolonged PTT in any factor deficiency VII
except?
bleeding immediately after trauma, Thrombocytopenia <150,000
petechiae?
delayed bleeding in joints, tissue Coagulopathies
hematomas?
thrombocytopenia causes? post op within 2-4 days, cancer, cirrhosis, infections, malignancy, SLE
spontaneous bleeding, petechiae present? plt <10,000
1st diagnostic in ovarian cancer suspected pelvic exam and transvaginal US
patients?
surgical exploration definitive dx in? ovarian cancer
CA 125 >35 marker in 80%? ovarian cancer
1st line diagnostic in uterine cancer? pelvic sonogram; biopsy if lining >4mm
Leave the first rating
Save
Students also studied
Heme clinicals exam 2 Hematology ASCP BOC Advanced Pathophysiology Exam 2... MMSC
134 terms Teacher 377 terms Teacher 129 terms 103 term
watuwachafu Preview hillamwangi12 Preview Euro_Futbal Preview wat
Practice questions for this set
Learn 1 /7 Study with Learn
brain, spine, and blood cancers
Choose an answer
1 TNM cancer staging only in> 2 TNM cancer staging including>
3 TNM cancer staging excluding> 4 TNM cancer staging except in>
Don't know?
Terms in this set (129)
high probability for DVT? Wells Score >2
high probability for PE? Wells criteria >6
high risk for bleeding 0-3 months? >2 risk factors = no anticoagulation
contraindicated in renal patients and Factor Xa inhibitors
mechanical heart valve patients?
1st line anticoagulation in cancer patients? LMWH
all VTE treated in what patients? cancer patients
, CI in GFR <30 LMWH and Fondaparinux, prescribe heparin
high risk for VTE via padua prediction? >4, need pharmacologics unless high risk of bleeding >2
low risk padua prediction <4 in nonsurgical no prophylaxis needed
patients?
prophylaxis in orthopedic patients? LMWH for 10-14 days
most common inherited thrombophilia? Factor V Leiden
PCR testing- G20210A? Prothrombin Mutation
mutation on chromosome 3 PROS1 mutation in PRrotein S deficiency
anticoagulants except heparin and LMWH free protein S levels, protein C function assay, and antithrombin functional assay
& VTE within 3 months interferes with what
testing?
hemophilia A factor deficiency? factor VIII, sex linked recessive
factor replacement and dDAVP treatment? hemophilia A
factor ? in hemophilia B? factor IX
? prolonged in hemophilias? PTT
ADAMTS13 deficient <10% confirms Dx? Thrombotic thrombocytopenia purpura TTP
plasma vWF <30 and factor VIII normal? Von Willebrand Disease
treatment of type 1 and some of type 2 dDAVP
vWD?
treatment of some type 2 and all type 3 recombinant vWF
vWD?
LDH high, bilirubin high? TTP and ITP
dexamethasone slows destruction of plts TTP and ITP
in?
transfuse plt in TTP or ITP when? severe bleeding or plt <30,000
plt destruction and the severe form? HIT 2
DX of HIT 2? ELISA OD >1.5 and high 4T score probability and serotonin release assay
1st choice DOAC in nonbleeding HIT 2 Argatroban IV to reduce HIT thrombosis
patients?
prolonged PTT in any factor deficiency VII
except?
bleeding immediately after trauma, Thrombocytopenia <150,000
petechiae?
delayed bleeding in joints, tissue Coagulopathies
hematomas?
thrombocytopenia causes? post op within 2-4 days, cancer, cirrhosis, infections, malignancy, SLE
spontaneous bleeding, petechiae present? plt <10,000
1st diagnostic in ovarian cancer suspected pelvic exam and transvaginal US
patients?
surgical exploration definitive dx in? ovarian cancer
CA 125 >35 marker in 80%? ovarian cancer
1st line diagnostic in uterine cancer? pelvic sonogram; biopsy if lining >4mm
